2024
Tackling the excesses of pharmaceutical marketing and promotion
Gupta R, Ramachandran R, Ross J. Tackling the excesses of pharmaceutical marketing and promotion. The BMJ 2024, 385: e076797. PMID: 38772671, DOI: 10.1136/bmj-2023-076797.Peer-Reviewed Original Research
2021
Covid-19, open science, and the CVD-COVID-UK initiative
Ross JS. Covid-19, open science, and the CVD-COVID-UK initiative. The BMJ 2021, 373: n898. PMID: 33827892, DOI: 10.1136/bmj.n898.Commentaries, Editorials and Letters
2011
Advanced Access Scheduling Outcomes: A Systematic Review
Rose KD, Ross JS, Horwitz LI. Advanced Access Scheduling Outcomes: A Systematic Review. JAMA Internal Medicine 2011, 171: 1150-1159. PMID: 21518935, PMCID: PMC3154021, DOI: 10.1001/archinternmed.2011.168.Peer-Reviewed Original Research
2007
What have we learnt from Vioxx?
Krumholz HM, Ross JS, Presler AH, Egilman DS. What have we learnt from Vioxx? The BMJ 2007, 334: 120. PMID: 17235089, PMCID: PMC1779871, DOI: 10.1136/bmj.39024.487720.68.Commentaries, Editorials and Letters